USPTO serial 86748436
PREMUNE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHADAB, SETH WILLIG
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PREMUNE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
111 43 Stockholm, SE
111 43 Stockholm, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan M. Natland
SUSAN M. NATLAND Knobbe Martens Olson & Bear Llp2040 Main St Fl 14Irvine, CA 92614-8214UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Bacterial cultures for addition to food and feed products for animals; Chemical and biological immunoassay reagents, other than for medical use; Immunoassay reagents, other than for medical use, specifically used for science and research; Bacterial substances, namely, preparations for scientific use; Diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria for scientific purposes; Proteins in raw material form for use in science in the nature of scientific research; Proteins for use in the manufacture of food products for animals | ACTIVE | — |
| 003 | Non-medicated animal grooming preparations, namely, hair rinses, lotions, creams, and hair sprays and body sprays; Shampoo for animals; Cosmetics for animals; Breath fresheners and non-medicated dental rinses for animals; Deodorants for animals; body washes for animals; Non-medicated skin care preparations, namely, sprays, balms, ointments, gels, creams, washes, and rinses for animals | ACTIVE | — |
| 005 | Veterinary preparations and substances for the prevention and treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, acute and chronic diarrhea, cancer, autoimmune diseases, eczema and psoriasis; Veterinary diagnostic reagents; Medicines for veterinary purposes for the prevention and treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, dental disease, periodontal disease, inflammatory diseases, acute pain, chronic pain, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, acute and chronic diarrhea, cancer, autoimmune diseases, eczema and psoriasis; Probiotic bacterial formulations for veterinary use; Pharmaceutical preparations for veterinary use for the prevention and treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, dental disease, periodontal disease, acute pain, chronic pain, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, acute and chronic diarrhea, cancer, autoimmune diseases, eczema and psoriasis for veterinary medical purposes; Pharmaceutical preparations for veterinary use, namely, immunotherapeutic agents and pharmaceutical preparations for modulating cells of the immune system; Biological preparations for veterinary purposes for the prevention and treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, dental disease, periodontal disease, acute pain, chronic pain, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, acute and chronic diarrhea, cancer, autoimmune diseases, eczema and psoriasis; Biological preparations for veterinary purposes, namely, immunological antibodies for veterinary purposes; Biological preparations for veterinary purposes, namely, immunological antisera for veterinary purposes; Chemical preparations for veterinary purposes for the prevention and treatment of diseases, namely, immunologic diseases, microbiologic diseases, dental disease, periodontal disease, acute pain, chronic pain, gastrointestinal diseases, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, acute and chronic diarrhea, cancer, autoimmune diseases, eczema and psoriasis; Cultures of microorganisms for medical and veterinary use; Dietetic substances adapted for veterinary use, namely, dietary and nutritional supplements for veterinary use; Dietetic substances adapted for veterinary use, namely, dietary food supplements for veterinary use; Dietetic substances adapted for veterinary use, namely, dietary supplements for animals; Dietetic food adapted for veterinary use, namely, dietary and nutritional supplements for veterinary use; Dietetic food adapted for veterinary use, namely, dietary food supplements for veterinary use; Dietetic food adapted for veterinary use, namely, dietary supplements for animals; Chemical reagents for medical or veterinary purposes; Medicines for the prevention and treatment of diseases, namely, immunologic diseases, microbiologic diseases, gastrointestinal diseases, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, acute and chronic diarrhea, dental disease, periodontal disease, acute pain, chronic pain, cancer, autoimmune diseases, eczema and psoriasis; Allergy medications; Bacterial formulations for medical and veterinary use; Bacteriological preparations for medical and veterinary use; Bacteriological preparations for medical and veterinary use, namely, bacterial preparations for disease prevention; Media for bacteriological cultures; Immunotherapeutic agents for bacterial infections; Bacterial preparations for medical and veterinary use; Medicated supplements for foodstuffs for animals; Medicated animal washes, namely, medicated body washes; Animal flea collars; Repellents for animals; Antiparasitic collars for animals; Skin treatments, namely, medicated skin care preparations for animals; Medicated skin care preparations, namely, sprays, balms, ointments, gels, creams, washes, and rinses for animals; Powders for killing fleas on animals; Medicated animal grooming preparations, namely, hair rinses, lotions, creams, and hair sprays and body sprays; Medicated dental rinses; Wound dressings; Transdermal drug-emitting patches in the nature of pharmaceutical preparations for treatment of immunologic diseases, microbiologic diseases, gastrointestinal diseases, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, acute and chronic diarrhea, dental disease, periodontal disease, acute pain, chronic pain, cancer, autoimmune diseases, eczema and psoriasis; Drug delivery agents, consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for the treatment of immunologic diseases, microbiologic diseases, gastrointestinal diseases, inflammatory diseases, viral diseases, immunodeficiency disorders, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, acute and chronic diarrhea, dental disease, periodontal disease, acute pain, chronic pain, cancer, autoimmune diseases, eczema and psoriasis; Veterinary and medical diagnostic reagents and assays, namely, immunological assays and reagents, for measuring immune analytes and markers, all of the foregoing for non-human animal and veterinary use only | ACTIVE | — |
| 010 | Veterinary apparatus and instruments, namely, drug delivery devices, namely, transdermal drug-emitting patches, drug delivery depots, and endogenous drug transporters sold without medication; Drug delivery devices in the nature of canisters for containing medication or disinfection products; Veterinary apparatus and instruments, namely, diagnostic equipment in the nature of X-ray diagnostic apparatus, MRI diagnostic apparatus, diagnostic catheters and medical instrument for cardiovascular diagnostics; Veterinary apparatus and instruments, namely, ultrasonic medical diagnostic apparatus; Veterinary apparatus and instruments for diagnostic use, namely, apparatus for veterinary medical diagnostic testing in the fields of infectious, immune-mediated or gastrointestinal diseases; Veterinary apparatus and instruments for diagnostic radiopharmaceutical use; Veterinary apparatus and instruments, namely, rigid and flexible veterinary medical endoscopes; Veterinary apparatus and instruments, namely, device for in vitro diagnostics for veterinary medical use; veterinary apparatus and instruments, namely, electronic medical endoscope, and joint surgery devices, namely, artificial limbs, orthopedic articles, namely, surgical implants made of artificial materials, veterinary medical guidewires, surgical apparatus and instruments for orthopedic surgery, artificial bone implants, artificial joint implants, artificial spinal column implants, specialized surgical tools for inserting implants, braces for limbs and joints, artificial eyes and teeth; Veterinary apparatus and instruments, namely, immunological assay equipment and assay equipment supplies for measuring immune analytes and markers for medical and veterinary and diagnostic use; Diagnostic testing instruments for use in immunoassay procedure; Veterinary diagnostic apparatus for the detection of immunologic diseases, microbiologic diseases, gastrointestinal diseases, inflammatory diseases, viral diseases, immunodeficiency diseases, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, acute and chronic diarrhea, dental disease, periodontal disease, acute pain, chronic pain, cancer, autoimmune diseases, eczema and psoriasis | ACTIVE | — |
| 031 | Foodstuffs and fodder for animals; Food preparations for dogs, namely, dog food; Food preparations for cats, namely, cat food | ACTIVE | — |
| 042 | Research on the subject of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; Drug discovery services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical drug development services; Bacteriological research; Bacteriological research and testing; Research and development in the pharmaceutical and biotechnology fields; Bacteriological analysis; Research and testing services in the fields of bacteriology and virology; Research and development of vaccines and medicines; Biochemical analysis; Veterinary laboratory services; Pharmaceutical research services for assessing the efficiency of veterinary drugs | ACTIVE | — |
| 044 | Preparation and dispensing of medications; Medical analysis services in the nature of medical diagnosis for immunologic diseases, microbiologic diseases, gastrointestinal diseases, inflammatory diseases, viral diseases, immunodeficiency diseases, allergies, dermatitis, bacterial infections, otitis, inflammatory bowel disease, acute and chronic diarrhea, dental disease, periodontal disease, acute pain, chronic pain, cancer, autoimmune diseases, eczema and psoriasis, blood glucose and hormone concentrations; Providing veterinary pharmaceutical industry information services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Premune AB
- Other trademarks owned by Premune AB
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 031
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PREMUNE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 30, 2017 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 30, 2017 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 28, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 31, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 31, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 11, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 23, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 23, 2016 | ALIE | ASSIGNED TO LIE | — |
| Dec 2, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 2, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 2, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 2, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 2, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 14, 2016 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 14, 2016 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 14, 2016 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 22, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 22, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 20, 2016 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 8, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 7, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 7, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 28, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 17, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 31, 2015 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Oct 23, 2015 | ALIE | ASSIGNED TO LIE | — |
| Oct 2, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Sep 9, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 8, 2015 | NWAP | NEW APPLICATION ENTERED | — |